# Commission Directive (EU) 2020/739 of 3 June 2020 amending Annex III to Directive 2000/54/EC of the European Parliament and of the Council as regards the inclusion of SARS-CoV-2 in the list of biological agents known to infect humans and amending Commission Directive (EU) 2019/1833, Annex

Extent: E+W+S+N.I.

In Annex III to Directive 2000/54/EC, in the table concerning VIRUSES (Order ‘Nidovirales’, Family ‘Coronaviridae’, Genus ‘Betacoronavirus’) the following entry is inserted between ‘Severe acute respiratory syndrome-related coronavirus (SARS-virus)’ and ‘Middle East respiratory syndrome coronavirus (MERS-virus)’:
In line with Article 16(1)(c), non-propagative diagnostic laboratory work involving SARS-CoV-2 should be conducted at a facility using procedures equivalent to at least containment level 2. Propagative work involving SARS-CoV-2 should be conducted at a containment level 3 laboratory with air pressure negative to atmosphere. ’
‘Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
3

---
Source: https://www.legislation.gov.uk/eudr/2020/739/annex (the official version)
Page: https://openlegislation.uk/eu-directive-2020-739/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.